This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jul 2;136(1):4-6.

doi: 10.1182/blood.2020005877.

Occupy BTK: the key to controlling CLL

Philip A Thompson¹

Affiliations

PMID: 32614961
DOI: 10.1182/blood.2020005877

Free article

Comment

Occupy BTK: the key to controlling CLL

Philip A Thompson. Blood. 2020.

Free article

. 2020 Jul 2;136(1):4-6.

doi: 10.1182/blood.2020005877.

Author

Philip A Thompson¹

Affiliation

¹ The University of Texas MD Anderson Cancer Center.

PMID: 32614961
DOI: 10.1182/blood.2020005877

No abstract available

PubMed Disclaimer

Comment on

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
Sun C, Nierman P, Kendall EK, Cheung J, Gulrajani M, Herman SEM, Pleyer C, Ahn IE, Stetler-Stevenson M, Yuan CM, Maric I, Gaglione EM, Harris HM, Pittaluga S, Wang MH, Patel P, Farooqui MZH, Izumi R, Hamdy A, Covey T, Wiestner A. Sun C, et al. Blood. 2020 Jul 2;136(1):93-105. doi: 10.1182/blood.2019003715. Blood. 2020. PMID: 32202637 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems